StockData
Solventum Corp logo

Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.48+0.42 (+0.49%)

Close on Nov 18, 2026Market cap $14.72BP/E 97.2Yield –

Solventum net income

Net income is the profit left for shareholders after every expense, interest and tax.

Solventum's net income for the twelve months ending Sep 30, 2026 was $156.00M, down 89.8% year over year. For fiscal 2025 it was $1.56B, up 224.8% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.56B+224.8%
FY2024Dec 31, 2024$479.00M-64.4%
FY2023Dec 31, 2023$1.35B+0.2%
FY2022Dec 31, 2022$1.34B–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$12.00M-100.9%
Q2 FY2026Jun 30, 2026$92.00M+2.2%
Q1 FY2026Mar 31, 2026$13.00M-90.5%
Q4 FY2025Dec 31, 2025$63.00M+103.2%
Q3 FY2025Sep 30, 2025$1.27B+937.7%
Q2 FY2025Jun 30, 2025$90.00M+1.1%
Q1 FY2025Mar 31, 2025$137.00M-42.2%
Q4 FY2024Dec 31, 2024$31.00M-88.6%
Q3 FY2024Sep 30, 2024$122.00M-73.5%
Q2 FY2024Jun 30, 2024$89.00M-72.3%
Q1 FY2024Mar 31, 2024$237.00M-19.1%
Q4 FY2023Dec 31, 2023$272.00M–
Q3 FY2023Sep 30, 2023$460.00M–
Q2 FY2023Jun 30, 2023$321.00M–
Q1 FY2023Mar 31, 2023$293.00M–

More Solventum figures

See a number that looks wrong?